MILBEMAX 1-5KG 4 TABLETS | INTERNAL ANTIPARASITIC SMALL DOG

MILBMAX

MILBEMAX CHEWABLE TABLETS FOR SMALL DOGS AND PUPPIES

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

One chewable tablet contains:

Active substances:

Milbemycin oxime 2,5 mg
Praziquantel 25,0 mg
Excipients:
Glycerol (E 422) 92,12 mg
Propylene glycol (E 1520) 0,91 mg
Iron oxide, brown (E 172) 0,66 mg
Butylated hydroxyanisole (E 320) 0,26 mg

Propyl gallate (E 310) 0,9 mg

For the full list of excipients, see section 6.1.

3 PHARMACEUTICAL FORM

Chewable tablet.
Oval shape, dark brown.
4. CLINICAL DATA

4.1 Target species

Dogs

MILBMAX

4.2 Indications for use, specifying the target species
In dogs: treatment of mixed infections by adult cestodes and nematodes of the
following species:
– Cestodes:
Canine dipylidium
Taenia spp.
Echinococcus spp.
Mesocestoides spp.
– Nematodes:
Ancylostoma caninum
toxocara canis
Toxascaris leonina
Trichuris vulpis
Crenosome vulpis (Reduction of the level of infection).

Angiostrongylus vasorum (Reduction of the level of infection) (see the treatment scheme
specific in section 4.9 “Posology and route of administration”).
The drug can also be used in the prevention of heartworm (Unforgiving heartworms),
if concomitant treatment against cestodes is indicated.
4.3 Contraindications
Do not use in dogs weighing less than 5 kg.
Do not use in case of hypersensitivity to the active substances or to any of the excipients.
See also section 4.5 “Special precautions for use”.
4.4 Special warnings
Studies with milbemycin oxime indicate that the margin of safety in some dogs of
Collie or related breed is inferior to that of other breeds. In these dogs, one should observe
strictly the recommended dosage.
The tolerance of the drug in puppies of these breeds has not been studied.
Clinical symptoms in Collies are similar to those seen in the general population of
overdosed dogs (see section 4.10 “Overdose”).

Special precautions to be taken by the person administering the medicinal product to animals
Wash your hands after use.
In case of accidental ingestion of the tablets, especially in the case of children, consult with a
doctor and show him the label and/or package leaflet.
4.6 Adverse reactions (frequency and seriousness)
On very rare occasions, systemic signs (such as lethargy) have been observed.
neurological (such as muscle tremors and ataxia) and/or gastrointestinal (such as
emesis, drooling, diarrhea and anorexia) in dogs after drug administration
vet.
4.7 Use during pregnancy, lactation or lay
The safety of the veterinary medicinal product has been established during pregnancy and lactation.
It can be used in pregnant and lactating bitches.
It can be used in breeding animals.
4.8 Interaction with other medicinal products and other forms of interaction
The concomitant use of the drug with selamectin is well tolerated. were not observed
interactions when the recommended dose of the macrocyclic lactone was administered
selamectin during treatment with the drug at the recommended dose. In absence
from other studies, caution should be taken in the case of concomitant use of the drug and
other macrocyclic lactoses. No such studies have been performed in breeding animals.
4.9 Amounts to be administered and administration route
Recommended minimum dose: 0,5 mg milbemycin oxime and 5 mg praziquantel per kg in
single dose orally. The drug should be administered with or after some of
food.
Depending on the weight of the dog, the practical dose is as follows:

In cases where heartworm prevention is being carried out and at the same time
need treatment against cestodes, MILBEMAX can replace the medicine
monovalent in the prevention of filariasis.
For infections of Angiostrongylus vasorum, milbemycin oxime four should be administered
times at weekly intervals. Recommended, where treatment is indicated

concomitant cestodes, treat once with the drug and continue with the
monovalent drug containing milbemycin oxime only, during the three
remaining weekly treatments.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
The adverse reactions observed are the same as those observed at the dose
recommended (see section 4.6 “Adverse reactions (frequency and seriousness)”), but more
pronounced.
4.11 Timeout
Not applicable.

6. PHARMACEUTICAL DATA
6.1 List of excipients
Glycerol (E 422)
Propylene glycol (E 1520)
Iron oxide, brown (E 172)
Butylated hydroxyanisole (E320)
Propyl gallate (E 310)
Pregelatinized starch.
natural chicken flavor
confectioners sugar
Purified water
Sodium chloride
Citric acid monohydrate
6.2 Incompatibilities
Not applicable.
6.3 Validity period
Shelf life of the veterinary medicinal product packaged for sale: 3 years.
6.4. Special storage precautions
Do not store at temperatures above 25°C.

MILBMAX

See technical sheet